RNTX
Price:
$0.9579
Market Cap:
$26.78M
Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren D...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2017-06-29
Stock Exchange
NASDAQ
Ticker
RNTX
According to Rein Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -55.75% compared to the average of -1.13 of the last 4 quarters.
The mean historical PE Ratio of Rein Therapeutics Inc. over the last ten years is -307.93. The current -0.50 PE Ratio has changed -83.76% with respect to the historical average. Over the past ten years (40 quarters), RNTX's PE Ratio was at its highest in in the June 2016 quarter at 0. The PE Ratio was at its lowest in in the June 2023 quarter at -1346.80.
Average
-307.93
Median
-0.62
Minimum
-1746.54
Maximum
0
Discovering the peaks and valleys of Rein Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -1746.54
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.59 | -9.79% |
| 2024 | -0.66 | -99.89% |
| 2023 | -619.61 | 75.97% |
| 2022 | -352.11 | -2.13% |
| 2021 | -359.76 | -79.40% |
| 2020 | -1746.54 | -Infinity% |
| 2019 | 0 | 0% |
| 2018 | 0 | 0% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
The current PE Ratio of Rein Therapeutics Inc. (RNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-206.95
5-year avg
-266.55
10-year avg
-307.93
Rein Therapeutics Inc.’s PE Ratio is less than Inotiv, Inc. (-0.03), greater than HeartBeam, Inc. (-1.52), greater than 111, Inc. (-3.85), less than Tempest Therapeutics, Inc. (-0.32), less than BioAtla, Inc. (-0.11), greater than Kezar Life Sciences, Inc. (-1.18), less than Celularity Inc. (-0.20), greater than Actinium Pharmaceuticals, Inc. (-1.34), greater than Mersana Therapeutics, Inc. (-2.07), greater than Quantum BioPharma Ltd. (-0.56),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.03 | $2.79M | |
| -1.52 | $26.10M | |
| -3.85 | $42.72M | |
| -0.32 | $5.60M | |
| -0.11 | $4.87M | |
| -1.18 | $53.86M | |
| -0.20 | $17.15M | |
| -1.34 | $31.69M | |
| -2.07 | $145.36M | |
| -0.56 | $17.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rein Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rein Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Rein Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Rein Therapeutics Inc. (RNTX)?
What is the highest PE Ratio for Rein Therapeutics Inc. (RNTX)?
What is the 3-year average PE Ratio for Rein Therapeutics Inc. (RNTX)?
What is the 5-year average PE Ratio for Rein Therapeutics Inc. (RNTX)?
How does the current PE Ratio for Rein Therapeutics Inc. (RNTX) compare to its historical average?